Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Developing Pan-Variant TKIs to Fight Treatment Resistant Cancer Mutations with Tim Clackson Theseus Pharmaceuticals TRANSCRIPT
Download PDFFeb 28, 2022
Tim Clackson is the President and CEO of Theseus Pharmaceuticals which has a mission to outsmart cancer resistance by developing pan-variant tyrosine kinase inhibitors (TKIs) that are designed to hit different types of cancer cell mutations. The goals of the therapy are to delay treatment resistant cancer as well as...
Feb 28, 2022
Tim Clackson is the President and CEO of Theseus Pharmaceuticals which has a mission to outsmart cancer resistance by developing pan-variant tyrosine kinase inhibitors (TKIs) that are designed to hit different types of cancer cell mutations. The goals of the therapy are to delay treatment resistant cancer as well as...
Feb 24, 2022
Dr. John Krakauer is the Chief Medical Advisor at MindMaze, pioneers in digital neurotherapeutics focused on brain health and recovery from neurological diseases and injuries.
John explains, "What we really mean by digital neurotherapeutics is the belief that one can actually administer a medicine in a way that's...
Advocating for Patient Access to Family and Care Providers with Emee Baldwin Poppy’s Purpose TRANSCRIPT
Download PDFFeb 23, 2022
Emee Baldwin, Founder of Poppy's Purpose, is a nursing student and patient advocate with a success story about getting the attention of care providers and elected officials to re-evaluate the rules regarding patient visitation rights, particularly in the age of COVID-19. Emee and her family worked with their local...
Feb 23, 2022
Emee Baldwin, Founder of Poppy's Purpose, is a nursing student and patient advocate with a success story about getting the attention of care providers and elected officials to re-evaluate the rules regarding patient visitation rights, particularly in the age of COVID-19. Emee and her family worked with their local...